Immunovant (IMVT) Retained Earnings (2018 - 2026)
Immunovant (IMVT) posted Retained Earnings of -$1.7 billion for Q1 2026, down 9.25% on a QoQ basis from -$1.6 billion in Q4 2025, and down 119709.32% year-over-year from N/an in Q1 2025.
Immunovant (IMVT) Retained Earnings (2018 - 2026) Analysis & Trends
Immunovant's Retained Earnings history runs 9 years deep, the most recent figure standing at -$1.7 billion for Q1 2026.
- Quarterly Retained Earnings fell 119709.32% year-over-year to -$1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 billion (down 119709.32% YoY) and the FY2026 annual result came in at -$1.7 billion, down 119709.32% from the prior year.
- Retained Earnings was -$1.7 billion for Q1 2026 at Immunovant, down from -$1.6 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $2.0 billion in Q3 2025 and bottomed at -$1.7 billion in Q1 2026.
- A 5-year average of -$315.5 million and a median of -$355.4 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings surged 357344.87% — and 2024, when it plunged 199310.92%.
- Immunovant's Retained Earnings stood at $920.2 million in 2022, then sank by 181.54% to -$750.4 million in 2023, then slumped by 51.0% to -$1.1 billion in 2024, then tumbled by 40.97% to -$1.6 billion in 2025, then retreated by 9.25% to -$1.7 billion in 2026.
- Business Quant data shows IMVT's Retained Earnings at -$1.7 billion in Q1 2026, -$1.6 billion in Q4 2025, and $2.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | -1.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.75 Bn |
| Dec 31, 2025 | -1.60 Bn |
| Sep 30, 2025 | 2.00 Bn |
| Jun 30, 2025 | -1.36 Bn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | -1.13 Bn |
| Sep 30, 2024 | -1.02 Bn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | -825.68 Mn |
| Dec 31, 2023 | -750.36 Mn |
| Sep 30, 2023 | 513,000.00 |
| Jun 30, 2023 | 939.55 Mn |
| Mar 31, 2023 | 852,000.00 |
| Dec 31, 2022 | 920.20 Mn |
| Sep 30, 2022 | -443.70 Mn |
| Jun 30, 2022 | -263,000.00 |
| Mar 31, 2022 | -355.39 Mn |
| Dec 31, 2021 | -308.20 Mn |
| Sep 30, 2021 | -266.83 Mn |
| Jun 30, 2021 | -229.13 Mn |